John P. Wargo
2 Papers
John P. Wargo is an academic researcher. The author has contributed to research in topics: Exposure assessment & Water quality. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
Lauren E. Colbert,Molly B. El Alam,Erica Lynn,Julianna K. Bronk,Tatiana Karpinets,X. Wu,B. Chapman,Travis T. Sims,D J Lin,Ramez Kouzy,Julie Sammouri,Greyson Biegert,Andrea Y. Delgado Medrano,Adilene Olvera,Jairam Sastry,Patricia J. Eifel,Anjua Jhingran,Li Lin,Lois M. Ramondetta,P. Andrew Futreal,Amir A. Jazaeri,Kathleen M. Schmeler,J. Yue,A. Mitra,Kyoko Yoshida-Court,John P. Wargo,Travis Solley,V. Hedge,Sita Nookala,Ananta V. Yanamandra,S. Dorta-Estamera,Geena Mathew,R. Kavukuntla,C. Papso,Mustapha Ahmed-Kaddar,M. Kim,J. Zhang,A. Reuben,E. Holliday,Bernard Minsky,A. A. Koong,Eugene J. Koay,Prerna Das,Cassio Taniguchi,Ann H. Klopp +44 more
TL;DR: In HPV16+ patients, improved recurrence-free survival was associated with HPV-responsive T-cell expansion during chemoradiotherapy, and this work lays the groundwork for understanding radiation-induced immune response among other cancers.
10
A Human Health Risk Assessment of Pharmaceuticals in the Aquatic Environment
Lisa J. Schulman,Edward V. Sargent,Bruce D. Naumann,Ellen C. Faria,David G. Dolan,John P. Wargo +5 more
TL;DR: The overall conclusion was that based on available data, no appreciable risk to humans exists, as the detected concentrations of each of these pharmaceutical compounds found in aqueous media were far below the derived safe limits.